Abstract
Most cases of primary hyperparathyroidism are caused by a single parathyroid adenoma. Minimally invasive parathyroidectomy for parathyroid adenomas can be performed in the outpatient setting; patients are typically discharged from the recovery room within hours after surgery if they meet discharge criteria. This chapter reviews the concept of outpatient parathyroidectomy, optimal preoperative localization algorithms, patient selection criteria, technical surgical aspects, and safety and outcomes of outpatient parathyroidectomy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kaplan EL, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s. Choice of surgical procedures for this disease. Ann Surg. 1992;215(4):300–17. Clinical Review; Level 2; Grade C.
Russell CF, Dolan SJ, Laird JD. Randomized clinical trial comparing scan-directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary adenoma. Br J Surg. 2006;93(4):418–21. Clinical Investigation; Level 1; Grade B.
Russell CF, Laird JD, Ferguson WR. Scan-directed unilateral cervical exploration for parathyroid adenoma: a legitimate approach? World J Surg. 1990;14(3):406–9. Clinical Investigation; Level 2; Grade B.
Hsi ED, Zukerberg LR, Yang WI, Arnold A. Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab. 1996;81(5):1736–9. Basic Science. Level 1; Grade A.
Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene. 1991;6(3):449–53. Basic Science Review; Level 1; Grade B.
Vasef MA, Brynes RK, Sturm M, Bromley C, Robinson RA. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. Mod Pathol. 1999;12(4):412–6. Basic Science; Level 1; Grade A.
Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, Gallagher J, Wild Y, Saucier K. Molecular pathogenesis of primary hyperparathyroidism. J Bone Miner Res. 2002;17 Suppl 2:N30–6. Basic Science Review; Level 1; Grade B.
Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ. Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet. 1997;16(4):375–8. Basic Science Review; Level 1; Grade B.
Sosa JA, Udelsman R. Minimally invasive parathyroidectomy. Surg Oncol. 2003;12(2):125–34. Clinical Review; Level 2; Grade C.
Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg. 2011;253(3):585–91. Clinical Investigation; Level 2; Grade B.
Phillips CD, Shatzkes DR. Imaging of the parathyroid glands. Semin Ultrasound CT MR. 2012;33(2):123–9. Clinical Review; Level 2; Grade B.
Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012;19(2):577–83. Clinical Review; Level 2; Grade C.
Hetrakul N, Civelek AC, Stagg CA, Udelsman R. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria. Surgery. 2001;130(6):1011–8. Basic Science Review; Level 1; Grade B.
Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med. 2005;35(4):266–76. Clinical Review; Level 2; Grade C.
Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, Scheidhauer K, Wester HJ, Rummeny EJ, Schwaiger M, Drzezga A. SPECT/CT. J Nucl Med. 2008;49(8):1305–19. Basic Science Review; Level I; Grade B.
Lal A, Chen H. The negative sestamibi scan: is a minimally invasive parathyroidectomy still possible? Ann Surg Oncol. 2007;14(8):2363–6. Clinical Review; Level 3, Grade C.
Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery. 2002;131(2):149–57. Clinical Review; Level 3; Grade A.
Bahl M, Sepahdari AR, Sosa JA, Hoang JK. Parathyroid adenomas and hyperplasia on four-dimensional CT scans: three patterns of enhancement relative to the thyroid gland justify a three-phase protocol. Radiology. 2015;29:142393. Clinical Review; Level 3; Grade A.
Lopez Hanninen E, Vogl TJ, Steinmuller T, Ricke J, Neuhaus P, Felix R. Preoperative contrast-enhanced MRI of the parathyroid glands in hyperparathyroidism. Invest Radiol. 2000;35(7):426–30. Clinical Review; Level 3; Grade A.
Wakamatsu H, Noguchi S, Yamashita H, Yamashita H, Tamura S, Jinnouchi S, Nagamachi S, Futami S. Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. Nucl Med Commun. 2003;24(7):755–62. Clinical Investigation; Level 2; Grade B.
Wang TS, Cheung K, Farrokhyar F, Roman SA, Sosa JA. Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism. Surgery. 2011;150(6):1286–94. Clinical Investigation; Level 2; Grade A.
Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts Jr JT. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561–9. Clinical Review; Level 2; Grade A.
Perrier ND. Asymptomatic hyperparathyroidism: a medical misnomer? Surgery. 2005;137(2):127–31. Clinical Review; Level 5.
Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140(5):472–8. discussion 478–9. Clinical Investigation; Level 2; Grade B.
Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg. 2002;236(5):543–51. Clinical Investigation; Level 1; Grade B.
Black MJ, Ruscher AE, Lederman J, Chen H. Local/cervical block anesthesia versus general anesthesia for minimally invasive parathyroidectomy: what are the advantages? Ann Surg Oncol. 2007;14(2):744–9. Clinical Investigation; Level 2; Grade B.
Carneiro DM, Irvin III GL. Late parathyroid function after successful parathyroidectomy guided by intraoperative hormone assay (QPTH) compared with the standard bilateral neck exploration. Surgery. 2000;128(6):925–9;discussion 935–26. Clinical Investigation; Level 2; Grade B.
Carneiro DM, Solorzano CC, Irvin 3rd GL. Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg. 2004;199(6):849–53. discussion 853–845. Clinical Review; Level 3; Grade A.
Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin 3rd GL. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery. 2003;134(6):973–9. discussion 979–81. Clinical Review; Level 3; Grade A.
Irvin 3rd GL, Carneiro DM, Solorzano CC. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg. 2004;239(5):704–8. discussion 708–11. Clinical Investigation; Level 2; Grade B.
Irvin III GL, Molinari AS, Figueroa C, Carneiro DM. Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg. 1999;229(6):874–8. discussion 878–9. Clinical Investigation; Level 2; Grade B.
Thier M, Nordenstrom E, Bergenfelz A, Westerdahl J. Surgery for patients with primary hyperparathyroidism and negative sestamibi scintigraphy--a feasibility study. Langenbecks Arch Surg. 2009;394(5):881–4. Clinical Review; Level 3; Grade A.
Dixon JL, Snyder SK, Lairmore TC, Jupiter D, Govednik C, Hendricks JC. A novel method for the management of post-thyroidectomy or parathyroidectomy hematoma: a single-institution experience after over 4,000 central neck operations. World J Surg. 2014;38(6):1262–7. Clinical Review; Level 3; Grade A.
Schneider DF, Mazeh H, Chen H, Sippel RS. Predictors of recurrence in primary hyperparathyroidism: an analysis of 1386 cases. Ann Surg. 2014;259(3):563–8. Clinical Investigation; Level 2; Grade B.
Stack Jr BC, Spencer H, Moore E, Medvedev S, Bodenner D. Outpatient parathyroid surgery data from the University Health System Consortium. Otolaryngol Head Neck Surg. 2012;147(3):438–43. Population Study; Level 2; Grade B.
Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235(5):665–70. discussion 670–62. Clinical Investigation; Level 2; Grade B.
Schneider DF, Mazeh H, Sippel RS, Chen H. Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases. Surgery. 2012;152(6):1008–15. Clinical Investigation; Level 2; Grade B.
Kebebew E, Duh QY, Clark OH. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg. 2003;138(8):867–71. Clinical Review; Level 3; Grade A.
Thomas DC, Roman SA, Sosa JA. Parathyroidectomy in the elderly: analysis of 7313 patients. J Surg Res. 2011;170(2):240–6. Population Study; Level 2; Grade B.
Politz D, Norman J. Hyperparathyroidism in patients over 80: clinical characteristics and their ability to undergo outpatient parathyroidectomy. Thyroid. 2007;17(4):333–9. Clinical Investigation; Level 2; Grade B.
Shin SH, Holmes H, Bao R, Jimenez C, Kee SS, Potylchansky E, Lee JE, Evans DB, Perrier ND. Outpatient minimally invasive parathyroidectomy is safe for elderly patients. J Am Coll Surg. 2009;208(6):1071–6. Clinical Investigation; Level 2; Grade B.
Pitt SC, Panneerselvan R, Sippel RS, Chen H. Influence of morbid obesity on parathyroidectomy outcomes in primary hyperparathyroidism. Am J Surg. 2010;199(3):410–4. discussion 414–5. Clinical Investigation; Level 2; Grade B.
Norman J, Aronson K. Outpatient parathyroid surgery and the differences seen in the morbidly obese. Otolaryngol Head Neck Surg. 2007;136(2):282–6. Clinical Investigation; Level 2; Grade B.
Buerba R, Roman SA, Sosa JA. Thyroidectomy and parathyroidectomy in patients with high body mass index are safe overall: analysis of 26,864 patients. Surgery. 2011;150(5):950–8. Population Study; Level 2; Grade B.
Udelsman R, Akerstrom G, Biagini C, Duh QY, Miccoli P, Niederle B, Tonelli F. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3595–606. Clinical Review; Level 2; Grade A.
Starker LF, Akerström T, Long WD, Delgado-Verdugo A, Donovan P, Udelsman R, Lifton RP, Carling T. Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Horm Cancer. 2012;3(1-2):44–51. Basic Science Review; Level 1; Grade B.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Adam, M.A., Roman, S.A., Sosa, J.A. (2017). Outpatient Parathyroidectomy. In: Stack, Jr., B., Bodenner, D. (eds) Medical and Surgical Treatment of Parathyroid Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-26794-4_37
Download citation
DOI: https://doi.org/10.1007/978-3-319-26794-4_37
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26792-0
Online ISBN: 978-3-319-26794-4
eBook Packages: MedicineMedicine (R0)